JGH:梅奥评分和总胆固醇水平可以作为急性中重度溃疡性结肠炎患者诱导治疗期间粘膜愈合的预测因子

2019-06-28 不详 MedSci原创

粘膜愈合是溃疡性结肠炎治疗的最终目的,本项研究旨在确定在开始诱导治疗的3个月和12个月时预测溃疡性结肠炎粘膜愈合的标记物。

背景和目的
粘膜愈合是溃疡性结肠炎治疗的最终目的,本项研究旨在确定在开始诱导治疗的3个月和12个月时预测溃疡性结肠炎粘膜愈合的标记物。

方法
本项单中心前瞻性观察研究纳入了61例因疾病恶化而住院的溃疡性结肠炎成年患者,收集了部分Mayo评分,溃疡性结肠炎内镜下严重程度指数,粪便标记物和开始诱导的实验室数据(0天,2周,3个月和12个月)。

结果
在2周时,3个月时粘膜愈合的患者具有较低的局部Mayo和溃疡性结肠炎内镜指数,并且比没有粘膜愈合的患者具有更高的白细胞计数和总胆固醇。在3个月时,12个月时粘膜愈合的患者的部分Mayo和溃疡性结肠炎内镜指数的严重程度评分低于没有粘膜愈合的患者。

结论
在急性溃疡性结肠炎患者的诱导治疗期间,部分梅奥评分和总胆固醇水平可作为短期治疗靶点。3个月的粘膜愈合与较长时间的粘膜愈合相关。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1695094, encodeId=720e169509431, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Thu May 14 04:48:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655286, encodeId=4e0c165528609, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Mon Nov 04 23:48:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691036, encodeId=b4ef1691036ac, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Sun Feb 09 18:48:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310732, encodeId=4bec1310e3270, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368291, encodeId=02341368291a4, content=<a href='/topic/show?id=8a5e6242257' target=_blank style='color:#2F92EE;'>#梅奥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62422, encryptionId=8a5e6242257, topicName=梅奥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]
    2020-05-14 nymo
  2. [GetPortalCommentsPageByObjectIdResponse(id=1695094, encodeId=720e169509431, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Thu May 14 04:48:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655286, encodeId=4e0c165528609, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Mon Nov 04 23:48:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691036, encodeId=b4ef1691036ac, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Sun Feb 09 18:48:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310732, encodeId=4bec1310e3270, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368291, encodeId=02341368291a4, content=<a href='/topic/show?id=8a5e6242257' target=_blank style='color:#2F92EE;'>#梅奥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62422, encryptionId=8a5e6242257, topicName=梅奥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1695094, encodeId=720e169509431, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Thu May 14 04:48:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655286, encodeId=4e0c165528609, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Mon Nov 04 23:48:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691036, encodeId=b4ef1691036ac, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Sun Feb 09 18:48:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310732, encodeId=4bec1310e3270, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368291, encodeId=02341368291a4, content=<a href='/topic/show?id=8a5e6242257' target=_blank style='color:#2F92EE;'>#梅奥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62422, encryptionId=8a5e6242257, topicName=梅奥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]
    2020-02-09 guoyibin
  4. [GetPortalCommentsPageByObjectIdResponse(id=1695094, encodeId=720e169509431, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Thu May 14 04:48:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655286, encodeId=4e0c165528609, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Mon Nov 04 23:48:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691036, encodeId=b4ef1691036ac, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Sun Feb 09 18:48:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310732, encodeId=4bec1310e3270, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368291, encodeId=02341368291a4, content=<a href='/topic/show?id=8a5e6242257' target=_blank style='color:#2F92EE;'>#梅奥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62422, encryptionId=8a5e6242257, topicName=梅奥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1695094, encodeId=720e169509431, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Thu May 14 04:48:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655286, encodeId=4e0c165528609, content=<a href='/topic/show?id=966552e7237' target=_blank style='color:#2F92EE;'>#总胆固醇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52772, encryptionId=966552e7237, topicName=总胆固醇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741e24715588, createdName=ycmayy, createdTime=Mon Nov 04 23:48:00 CST 2019, time=2019-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691036, encodeId=b4ef1691036ac, content=<a href='/topic/show?id=7adce62603e' target=_blank style='color:#2F92EE;'>#粘膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76260, encryptionId=7adce62603e, topicName=粘膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=090129165428, createdName=guoyibin, createdTime=Sun Feb 09 18:48:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310732, encodeId=4bec1310e3270, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368291, encodeId=02341368291a4, content=<a href='/topic/show?id=8a5e6242257' target=_blank style='color:#2F92EE;'>#梅奥#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62422, encryptionId=8a5e6242257, topicName=梅奥)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Jun 30 12:48:00 CST 2019, time=2019-06-30, status=1, ipAttribution=)]

相关资讯

J Gastroenterology:表面微结构与结肠直肠肿瘤中异质性相关

最近的研究表明,结直肠肿瘤由遗传多样的亚克隆组成。本项研究旨在阐明结直肠肿瘤的表面微结构是否与遗传瘤内异质性(ITH)相关。

Gastroenterology:持续氯吡格雷治疗后息肉切除术出血的风险分析

目前临床医生的经验以及指南均建议在息肉切除术前7天暂停氯吡格雷的使用以降低患者行息肉切除术后出血风险,但这些都是基于有限的证据撰写的。本项研究了旨在探究不间断氯吡格雷治疗是否会增加接受结肠镜检查的患者术后息肉切除术术后出血的风险。

AJG: 通过放大图像增强内窥镜诊断结直肠腺瘤患者的晚期结直肠肿瘤发生率效果分析

随着技术的发展,越来越多的小型结直肠腺瘤被诊断出来,同时,“诊断-不切除”的切除替代方法引起了人们的注意。本项研究通过放大图像增强内窥镜评估了未治疗的小腺瘤患者的晚期结直肠肿瘤(ACN)累积发生率,并比较了无腺瘤患者的肿瘤发病率

Clin Gastroenterology H: 先前使用抗血栓药物可降低高危上消化道出血患者的死亡率和住院时间

传统的观点认为抗血栓形成剂的使用是上消化道出血(UGIB)的危险因素。然而,很少有研究评估它们对患者预后的影响。因此,本项研究评估了抗血栓形成剂对高风险UGIB患者预后的影响。

Clin Gastroenterology H: T1期食管鳞状细胞癌内镜黏膜下剥离与食管切除术的疗效比较

食管切除术是早期食管鳞状细胞癌(EESCC)的标准治疗方法,但接受该手术的患者发病率和死亡率较高。内镜黏膜下剥离术(ESD)是一种治疗EESCC的微创手术,但被认为是有风险的,因为这种肿瘤经常转移到淋巴结。因此,本项研究的目的是比较接受ESD治疗的EESCC患者与接受食管切除术的患者效果之间的效果差异。

Clin Gastroenterology H:无症状青年结直肠肿瘤的患病率和危险因素分析

50岁以下的人群中结肠直肠癌的发病率正在逐年增加。然而,有关年轻发病性结直肠肿瘤(CRN)流行病学的数据很有限。虽然一些研究调查了CRN在50岁以下人群中的流行病学数据,但大多数研究都集中在40岁或以上的人群。因此,本项研究旨在评估40岁以下成人CRN的患病率和危险因素。